Remove 2023 Remove Medical Evaluation Remove Safety
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

A 2023 study in Cannabis and Cannabinoid Research validated this approach, showing that patients following slower titration schedules had 84% treatment satisfaction compared to 61% with faster increases. The Stanford Sleep Laboratory Findings Stanford’s Sleep Research Center studied 847 insomnia patients using different cannabis doses.

article thumbnail

Rescheduling Marijuana

Connor & Connor PLLC

Currently, marijuana is a Schedule I substance, meaning it is thought to have no medical value, a high probability of addiction, and a lack of any accepted safety or use in medically supervised treatment. Currently, the underground marijuana economy has an estimated value of $66 billion annually (New Frontier Data, 2023).